Insulet Corporation - Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor

Omnipod 5 is the world’s first tubeless automated insulin delivery system to achieve CE mark approval with multiple continuous glucose monitoring (CGM) sensor brands. Latest Omnipod 5 integration is expected to be available in the United Kingdom and Netherlands in the first half of 2024, with additional markets to follow. Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has

Insulin Delivery Device Technology — Today and Into the Future - Today's Dietitian Magazine

ㅤ

Regulatory/Compliance Archives - Drug Delivery Business

Jonathan Matti on LinkedIn: NEW Freestyle Libre 2 Plus CGM For Tandem Pumps!

Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor

Trang Ly (@drtrangly) / X

Insulet Corporation on LinkedIn: Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin…

Insulet Corporation on LinkedIn: #teaminsulet

Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases

MedTech Dive on LinkedIn: Abbott gets approval for new rechargeable deep brain stimulation system

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes